India Exchange Filings

Glenmark Authorized Generic Launch

Glenmark Pharmaceuticals Ltd launches U.S. authorized generic axitinib tablets, 1 mg and 5 mg

  • Authorized generic version of INLYTA® (axitinib).
  • U.S. INLYTA® tablet sales were approximately $538.4 million for the 12 months ended September 2026, according to IQVIA.
  • Glenmark said the launch expands its U.S. portfolio and supports access to affordable treatments.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.